Kimura, Shun-ichi
,
Fujita, Hiroyuki http://orcid.org/0000-0002-6084-6863
Kato, Hideaki
Hiramoto, Nobuhiro
Hosono, Naoko
Takahashi, Tsutomu
Shigeno, Kazuyuki
Hatsumi, Naoko
Minamiguchi, Hitoshi
Miyatake, Junichi
Handa, Hiroshi
Akiyama, Nobu
Kanda, Yoshinobu
Yoshida, Minoru
Kiyoi, Hitoshi
Miyazaki, Yasushi
Naoe, Tomoki
Article History
Received: 21 March 2017
Accepted: 30 May 2017
First Online: 6 June 2017
Compliance with ethical standards
:
: Shun-ichi Kimura received honoraria from Pfizer, Astellas, Sumitomo Dainippon Pharma, and Nippon Kayaku. Hiroyuki Fujita received honoraria from Novartis and payment for manuscripts from Chugai Pharmaceutical. Tsutomu Takahashi received grants from Chugai Pharmaceutical, Kyowa Hakko Kirin, and Astellas, and honoraria from Chugai Pharmaceutical, Kyowa Hakko Kirin, Taiho Pharmaceutical, and Celgene Corporation. Hiroshi Handa received payment for consultancy from Takeda Pharmaceutical, grants, and honoraria from Kyowa Hakko Kirin, Chugai Pharmaceutical, Takeda Pharmaceutical, Novartis, Bristol-Myers Squibb, Ono Pharmaceutical, and Astellas. Nobu Akiyama received grants from Shionogi, Sumitomo Dainippon Pharma, Taisho Toyama Pharmaceutical, and Astellas, and payment for manuscripts from Taiho Pharmaceutical. Yoshinobu Kanda received grants from Astellas, Chugai Pharmaceutical, Kyowa Hakko Kirin, Shionogi, Sumitomo Dainippon Pharma, Pfizer, and Taisho Toyama Pharmaceutical, and honoraria from Pfizer, MSD, Astellas, Sumitomo Dainippon Pharma, and Kyowa Hakko Kirin. Minoru Yoshida received honoraria from Astellas, Sumitomo Dainippon Pharma, and MSD. Hitoshi Kiyoi received research funding from Chugai Pharmaceutical, Bristol-Myers Squibb, Kyowa Hakko Kirin, Zenyaku Kogyo, FUJIFILM Corporation, Nippon Boehringer Ingelheim, Astellas, and Celgene Corporation, consulting fees from Astellas and Daiichi Sankyo, and honoraria from Bristol-Myers Squibb and Pfizer. Yasushi Miyazaki received grants from Chugai Pharmaceutical, Kyowa Hakko Kirin, Astellas, and Novartis, and honoraria from Chugai Pharmaceutical, Kyowa Hakko Kirin, Astellas, Sumitomo Dainippon Pharma, Celgene Corporation, and Novartis. Other authors: none to declare.